These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11802720)

  • 1. Role of zinc ions in activation and inactivation of thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Bouma BN; Meijers JC
    Biochemistry; 2002 Jan; 41(4):1211-6. PubMed ID: 11802720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.
    Marx PF; Hackeng TM; Dawson PE; Griffin JH; Meijers JC; Bouma BN
    J Biol Chem; 2000 Apr; 275(17):12410-5. PubMed ID: 10777524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Dawson PE; Bouma BN; Meijers JC
    Biochemistry; 2002 May; 41(21):6688-96. PubMed ID: 12022872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
    Foley JH; Kim P; Nesheim ME
    J Biol Chem; 2008 Apr; 283(14):8863-7. PubMed ID: 18252711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP; Blombäck M
    Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into thrombin activatable fibrinolysis inhibitor function and regulation.
    Foley JH; Kim PY; Mutch NJ; Gils A
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():306-15. PubMed ID: 23809134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.
    Bazzi ZA; Balun J; Cavallo-Medved D; Porter LA; Boffa MB
    Clin Exp Metastasis; 2017 Feb; 34(2):155-169. PubMed ID: 28124276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin-activatable fibrinolysis inhibitor but not the anti-inflammatory activity on osteopontin and C5a.
    Semeraro F; Ammollo CT; Gils A; Declerck PJ; Colucci M
    J Thromb Haemost; 2013 Dec; 11(12):2137-47. PubMed ID: 24134522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
    J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.
    Bazzi ZA; Lanoue D; El-Youssef M; Romagnuolo R; Tubman J; Cavallo-Medved D; Porter LA; Boffa MB
    BMC Cancer; 2016 May; 16():328. PubMed ID: 27221823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T; Marquart JA; Marx PF; Meijers JC
    J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?
    Marx PF; Plug T; Havik SR; Mörgelin M; Meijers JC
    J Thromb Haemost; 2009 Mar; 7(3):445-52. PubMed ID: 19054324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there thrombin-activatable fibrinolysis inhibitor in saliva?
    Chopra S; Friman E; Krüger CW; Antovic JP; Naimi-Akbar A
    Br J Oral Maxillofac Surg; 2020 Nov; 58(9):e33-e37. PubMed ID: 32507642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-activatable fibrinolysis inhibitor.
    Marx PF
    Curr Med Chem; 2004 Sep; 11(17):2335-48. PubMed ID: 15379716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
    Boffa MB; Wang W; Bajzar L; Nesheim ME
    J Biol Chem; 1998 Jan; 273(4):2127-35. PubMed ID: 9442053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Havik SR; Bouma BN; Meijers JC
    J Thromb Haemost; 2005 Jun; 3(6):1293-300. PubMed ID: 15946220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor.
    Boffa MB; Bell R; Stevens WK; Nesheim ME
    J Biol Chem; 2000 Apr; 275(17):12868-78. PubMed ID: 10777585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
    Schneider M; Boffa M; Stewart R; Rahman M; Koschinsky M; Nesheim M
    J Biol Chem; 2002 Jan; 277(2):1021-30. PubMed ID: 11684677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
    Wang W; Boffa MB; Bajzar L; Walker JB; Nesheim ME
    J Biol Chem; 1998 Oct; 273(42):27176-81. PubMed ID: 9765237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.
    Incampo F; Carrieri C; Galasso R; Scaraggi FA; Di Serio F; Woodhams B; Semeraro N; Colucci M
    J Thromb Haemost; 2013 Feb; 11(2):315-24. PubMed ID: 23256818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.